Zota Health Care Limited has successfully raised ₹350 crores through a Qualified Institutional Placement (QIP) issue, allotting 22,80,130 equity shares at an issue price of ₹1,535 per share to a group of marquee investors. These investors include Valiant Partners, 360 ONE, 3P Investment Managers, White Oak Capital, Sanshi Fund-I, and Turnaround Opportunities Fund. Mr. Ketankumar Zota, Chairman of Zota Health Care Limited, expressed gratitude for the investors' confidence, highlighting that the funds will be used to accelerate the nationwide expansion of the Company-Owned Company-Operated (COCO) stores under the Davaindia brand. The proceeds will also cater to working capital requirements and general corporate purposes. The company aims to establish over 5,000 Davaindia stores, a mix of COCO and Franchisee-Owned Franchisee-Operated (FOFO) outlets, across India by March 2029. Currently, Zota operates 2,253 Davaindia stores, comprising 1,373 COCO stores and 880 FOFO stores. The company has observed a steady improvement in per-store revenues, driven by increasing consumer awareness and demand for affordable medicines. Zota Health Care focuses on providing quality generic medicines at significantly lower prices than branded alternatives, enhancing accessibility for a wider population.